Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis

<p>Abstract</p> <p>Background</p> <p>A verifiable consequence of the mutator hypothesis is that even low grade neoplasms would accumulate a large number of mutations that do not influence the tumor phenotype (clonal mutations). In this study, we have attempted to quanti...

Full description

Bibliographic Details
Main Authors: Sarkar Chitra, Chosdol Kunzang, Chattopadhyay Parthaprasad, Misra Anjan, Mahapatra Ashok K, Sinha Subrata
Format: Article
Language:English
Published: BMC 2007-10-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/7/190
_version_ 1818835865384779776
author Sarkar Chitra
Chosdol Kunzang
Chattopadhyay Parthaprasad
Misra Anjan
Mahapatra Ashok K
Sinha Subrata
author_facet Sarkar Chitra
Chosdol Kunzang
Chattopadhyay Parthaprasad
Misra Anjan
Mahapatra Ashok K
Sinha Subrata
author_sort Sarkar Chitra
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>A verifiable consequence of the mutator hypothesis is that even low grade neoplasms would accumulate a large number of mutations that do not influence the tumor phenotype (clonal mutations). In this study, we have attempted to quantify the number of clonal mutations in primary human gliomas of astrocytic cell origin. These alterations were identified in tumor tissue, microscopically confirmed to have over 70% neoplastic cells.</p> <p>Methods</p> <p>Random Amplified Polymorphic DNA (RAPD) analysis was performed using a set of fifteen 10-mer primers of arbitrary but definite sequences in 17 WHO grade II astrocytomas (low grade diffuse astrocytoma or DA) and 16 WHO grade IV astrocytomas (Glioblastoma Multiforme or GBM). The RAPD profile of the tumor tissue was compared with that of the leucocyte DNA of the same patient and alteration(s) scored. A quantitative estimate of the overall genomic changes in these tumors was obtained by 2 different modes of calculation.</p> <p>Results</p> <p>The overall change in the tumors was estimated to be 4.24% in DA and 2.29% in GBM by one method and 11.96% and 6.03% in DA and GBM respectively by the other. The difference between high and lower grade tumors was statistically significant by both methods.</p> <p>Conclusion</p> <p>This study demonstrates the presence of extensive clonal mutations in gliomas, more in lower grade. This is consistent with our earlier work demonstrating that technique like RAPD analysis, unbiased for locus, is able to demonstrate more intra-tumor genetic heterogeneity in lower grade gliomas compared to higher grade. The results support the mutator hypothesis proposed by Loeb.</p>
first_indexed 2024-12-19T02:57:30Z
format Article
id doaj.art-157061d669ec458390588ed1a3c6ee59
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-19T02:57:30Z
publishDate 2007-10-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-157061d669ec458390588ed1a3c6ee592022-12-21T20:38:17ZengBMCBMC Cancer1471-24072007-10-017119010.1186/1471-2407-7-190Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesisSarkar ChitraChosdol KunzangChattopadhyay ParthaprasadMisra AnjanMahapatra Ashok KSinha Subrata<p>Abstract</p> <p>Background</p> <p>A verifiable consequence of the mutator hypothesis is that even low grade neoplasms would accumulate a large number of mutations that do not influence the tumor phenotype (clonal mutations). In this study, we have attempted to quantify the number of clonal mutations in primary human gliomas of astrocytic cell origin. These alterations were identified in tumor tissue, microscopically confirmed to have over 70% neoplastic cells.</p> <p>Methods</p> <p>Random Amplified Polymorphic DNA (RAPD) analysis was performed using a set of fifteen 10-mer primers of arbitrary but definite sequences in 17 WHO grade II astrocytomas (low grade diffuse astrocytoma or DA) and 16 WHO grade IV astrocytomas (Glioblastoma Multiforme or GBM). The RAPD profile of the tumor tissue was compared with that of the leucocyte DNA of the same patient and alteration(s) scored. A quantitative estimate of the overall genomic changes in these tumors was obtained by 2 different modes of calculation.</p> <p>Results</p> <p>The overall change in the tumors was estimated to be 4.24% in DA and 2.29% in GBM by one method and 11.96% and 6.03% in DA and GBM respectively by the other. The difference between high and lower grade tumors was statistically significant by both methods.</p> <p>Conclusion</p> <p>This study demonstrates the presence of extensive clonal mutations in gliomas, more in lower grade. This is consistent with our earlier work demonstrating that technique like RAPD analysis, unbiased for locus, is able to demonstrate more intra-tumor genetic heterogeneity in lower grade gliomas compared to higher grade. The results support the mutator hypothesis proposed by Loeb.</p>http://www.biomedcentral.com/1471-2407/7/190
spellingShingle Sarkar Chitra
Chosdol Kunzang
Chattopadhyay Parthaprasad
Misra Anjan
Mahapatra Ashok K
Sinha Subrata
Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
BMC Cancer
title Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
title_full Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
title_fullStr Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
title_full_unstemmed Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
title_short Clonal mutations in primary human glial tumors: evidence in support of the mutator hypothesis
title_sort clonal mutations in primary human glial tumors evidence in support of the mutator hypothesis
url http://www.biomedcentral.com/1471-2407/7/190
work_keys_str_mv AT sarkarchitra clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis
AT chosdolkunzang clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis
AT chattopadhyayparthaprasad clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis
AT misraanjan clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis
AT mahapatraashokk clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis
AT sinhasubrata clonalmutationsinprimaryhumanglialtumorsevidenceinsupportofthemutatorhypothesis